PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.16%
Negative net income growth while MRVL stands at 45.10%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-2.53%
Both reduce yoy D&A, with MRVL at -6.28%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-314.29%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
48.72%
SBC growth while MRVL is negative at -12.11%. John Neff would see competitor possibly controlling share issuance more tightly.
-341.33%
Negative yoy working capital usage while MRVL is 350.19%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-198.60%
AR is negative yoy while MRVL is 157.74%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
30.74%
Some inventory rise while MRVL is negative at -50.76%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-239.08%
Negative yoy AP while MRVL is 5.36%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-200.33%
Both reduce yoy usage, with MRVL at -13.11%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-6000.00%
Negative yoy while MRVL is 3809.55%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-57.51%
Both yoy CFO lines are negative, with MRVL at -40.63%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
5.79%
Some CapEx rise while MRVL is negative at -12.75%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
28.82%
Purchases growth of 28.82% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
11.34%
We have some outflow growth while MRVL is negative at -9800.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
104.07%
We have mild expansions while MRVL is negative at -33.73%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-150.00%
We cut debt repayment yoy while MRVL is 5.27%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
35.63%
Issuance growth of 35.63% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-21.60%
Both yoy lines negative, with MRVL at -50.00%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.